Tag: Biocon
BioAsia 2018 witnesses intense deliberations over creating innovative bioscience ecosystem
The event that pitched Telangana as a strong contender to become the Gateway of India for biotechnology and life sciences, witnessed commitment from Biocon (Syngene) to set up its R&D unit in the state and generate 1500 new jobs...........
Biocon & Mylan’s biosimilar ‘Trastuzumab’ gets approval from Brazilian regulator
Co-developed by Biocon and Mylan, this is the first biosimilar Trastuzumab to be approved in Brazil and is indicated for the treatment of overexpressing HER2positive metastatic breast cancer. The product will be marketed by the Libbs Farmaceutica........
USFDA approves Mylan & Biocon´s biosimilar for breast, gastric cancers
Mylan anticipates potentially being the first company to provide patient access to a biosimilar to Herceptin, representing a significant milestone for Mylan, Biocon and the overall healthcare system........
Biocon confident of resolving issues with USFDA over biosimilar ‘pegfilgrastim’
While the company is set to launch proposed biosimilar, Pegfilgrastim in the United States market, the US Food and Drug Administration has issued Complete Response Letter (CRL) to it seeking more data on the cancer drug..............
Biocon & Mylan’s proposed biosimilar ‘Trastuzumab’ gets USFDA nod
The US-FDA Oncologic Drugs Advisory Committee has unanimously recommended approval of Mylan and Biocon’s proposed cancer targeting biosimilar, Trastuzumab.............
Biocon closes financial year 2017 with a strong revenue growth of...
Biocon reported a revenue of Rs 974 crore for quarter 4 of FY17 and a revenue of Rs 4,079 Cr for the entire FY17...........
BioVoice eMag April 2017 Issue-11 Volume-1
BioVoice eMag April 2017 Issue-11 Volume-1:
The ‘April 2017’ issue of BioVoice eMagazine includes the COVER STORY on Biorevolution 2.0: India’s quest to become a biotech...
USFDA accepts Mylan & Biocon’s proposed biosimilar Pegfilgrastim for review
The development marks the second successful biologics license application (BLA) for filing of the partnership in the United States of America...
India has 1022 biotech start-ups; $2.8 billion in biotech-led investments: ABLE’s...
The report compiled by the Association of Biotechnology Led Enterprises's in-house research team was first such study to map India’s biotech start-ups ecosystem...
Biocon wins INR 460 crore contract for Insulin from Malaysian govt
The company will supply rh-Insulin manufactured at its new facility in Malaysia to public sector hospitals and clinics through CCM Pharmaceuticals....